Home Newsfeeds Evercore ISI Group Initiates Coverage On ProKidney with Outperform Rating

Evercore ISI Group Initiates Coverage On ProKidney with Outperform Rating

Evercore ISI Group analyst Jonathan Miller initiates coverage on ProKidney (NASDAQ:PROK) with a Outperform rating.

byBenzinga Newsdesk

September 2, 2022

1 minute read

Evercore ISI Group analyst Jonathan Miller initiates coverage on ProKidney (NASDAQ:PROK) with a Outperform rating.

Ben & Jerry’s Sues Parent Unilever On Israeli business Sale: CNBC

By Shivani Kumaresan

July 6, 7:29 AM

Unilever Plc (NYSE:UL) owned Ben & Jerry’s has sued its owner to stop the sale of its Israeli business to…

Reported Late Tuesday Feb. 28, Faraday Future Announces Stockholder Approval Of Proposal To Increase The Authorized Shares Of Faraday Future Class A Common Stock To 1.69B

By Happy Mohamed

March 1, 1:23 AM

Stockholders also voted in favor of the Yorkville share issuance proposal to issue shares in excess of 19.99% of the issued and outstanding shares of the Company's common stock Vote comes after

FFIE

Benchmark Maintains Buy on Pinduoduo, Raises Price Target to $112

By Benzinga Newsdesk

November 29, 9:59 AM

Benchmark analyst Fawne Jiang maintains Pinduoduo (NASDAQ:PDD) with a Buy and raises the price target from $107 to $112.

PDD

Liberty Latin America Q4 Sales $1.16B Miss $1.19B Estimate

By Bill Haddad

February 22, 6:22 PM

Liberty Latin America (NASDAQ:LILA) reported quarterly sales of $1.16 billion which missed the analyst consensus estimate of $1.19 billion by 2.44 percent. This is a 9.23 percent decrease over sales of $1.28 billion the

LILA

Evercore ISI Group Initiates Coverage On ProKidney with Outperform Rating

Related Posts

Ben & Jerry’s Sues Parent Unilever On Israeli business Sale: CNBC

Reported Late Tuesday Feb. 28, Faraday Future Announces Stockholder Approval Of Proposal To Increase The Authorized Shares Of Faraday Future Class A Common Stock To 1.69B

Benchmark Maintains Buy on Pinduoduo, Raises Price Target to $112

Liberty Latin America Q4 Sales $1.16B Miss $1.19B Estimate